Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Bristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense November 13, 2017 Esperion Stock Gains On Strong Phase II Data August 7, 2017 NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results February 9, 2017
